INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
Go back to INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform| (NASDAQ: INMB) | Delayed: 1.50 +0.15 (11.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.35 | 52 Week High | $ | |||
| Open | $1.37 | 52 Week Low | $ | |||
| Day High | $1.53 | P/E | N/A | |||
| Day Low | $1.30 | EPS | $ | |||
| Volume | 10,928,773 | |||||
